Rectal NSAIDs for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials

Surgeon

Volumn 12, Issue 3, 2014, Pages 141-147

  Sun, Hong Li ^a   Han, Bing ^a   Zhai, Hong Peng ^b   Cheng, Xin Hua ^a   Ma, Kai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Endoscopic retrograde cholangiopancreatography; Meta analysis; Nonsteroidal anti inflammatory drugs; Pancreatitis; Rectal

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE EFFECTS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; META ANALYSIS; PANCREATITIS, ACUTE NECROTIZING; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTAL DRUG ADMINISTRATION;

ADMINISTRATION, RECTAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATITIS, ACUTE NECROTIZING; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84900346513     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2013.10.010     Document Type: Review

References (20)

1. Freeman M.L., Guda N.M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004, 59:845-864.
2. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001, 96:417-423.
3. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004, 60:544-550.
4. Brackbill S., Young S., Schoenfeld P., et al. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 2006, 64:45-52.
5. Gross V., Leser H.G., Heinisch A., et al. Inflammatory mediators and cytokines-new aspects of the pathophysiology and assessment of severity of acute pancreatitis?. Hepatogastroenterology 1993, 40:522-530.
6. Mäkelä A., Kuusi T., Schröder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997, 57:401-407.
7. Wildenhain P.M., Melhem M.F., Birsic W.I., et al. Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration. Digestion 1989, 44:41-51.
8. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124:1786-1791.
9. Sotoudehmanesh R., Khatibian M., Kolahdoozan S., et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007, 102:978-983.
10. Montaño Loza A., Rodríguez Lomelí X., García Correa J.E., et al. Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enferm Dig 2007, 99:330-336.
11. Khoshbaten M., Khorram H., Madad L., et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 2008, 23:e11-e16.
12. Otsuka T., Kawazoe S., Nakashita S., et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol 2012, 47:912-917.
13. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012, 366:1414-1422.
14. Döbrönte Z., Toldy E., Márk L., et al. Effects of rectal indomethacin in the prevention of post-ERCP pancreatitis. Orv Hetil 2012, 153:990-996.
15. Cotton P.B., Lehman G., Vennes J., Geenen J.E., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37:383-393.
16. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
17. Kjaergard L.L., Villumsen J., Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001, 135:982-989.
18. Cheon Y.K., Cho K.B., Watkins J.L., et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc 2007, 66:1126-1132.
19. Elmunzer B.J., Waljee A.K., Elta G.H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008, 57:1262-1267.
20. Ding X., Chen M., Huang S., et al. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc 2012, 76:1152-1159.